Topics

New gene therapy for wet age-related macular degeneration is on the horizon

05:21 EDT 11 Oct 2019 | News-Medical.net

Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks.

Original Article: New gene therapy for wet age-related macular degeneration is on the horizon

NEXT ARTICLE

More From BioPortfolio on "New gene therapy for wet age-related macular degeneration is on the horizon"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...